Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of CD5789 gel in acne vulgaris
2008-007981-44Phase 2Completed
- Sponsor
- Galderma
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of trifarotene in acne vulgaris (3 arms), sponsored by Galderma. Started Mar 2009; status: completed.
02
Drugs
trifarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2008-007981-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007981-44.